Toxins 2013, 5(5), 1010-1031; doi:10.3390/toxins5051010
Review

Sialorrhea: Anatomy, Pathophysiology and Treatment with Emphasis on the Role of Botulinum Toxins

1email, 2email and 1,* email
Received: 1 March 2013; in revised form: 9 April 2013 / Accepted: 24 April 2013 / Published: 21 May 2013
(This article belongs to the Special Issue Neurotoxins: Health Threats and Biological Tools)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Sialorrhea or excessive drooling is a major issue in children with cerebral palsy and adults with neurodegenerative disorders. In this review, we describe the clinical features, anatomy and physiology of sialorrhea, as well as a review of the world literature on medical treatment using Yale University’s search engine; including but not limited to Medline and Erasmus. Level of drug efficacy is defined according to the guidelines of American Academy of Neurology. Current medical management is unsatisfactory. Topical agents (scopolamine and tropicamide) and oral agents (glyccopyrolate) combined render a level B evidence (probably effective); however, this treatment is associated with troublesome side effects. Double-blind and placebo-controlled studies of botulinum toxin (BoNT) provide a level A evidence for type B (two class I studies; effective and established) and both overall and individual B level of evidence for OnabotulinumtoxinA (A/Ona) and AbobotulinumtoxinA (A/Abo); these are probably effective. For IncobotulinumtoxinA (A/Inco), the level of evidence is U (insufficient) due to lack of blinded studies. Side effects are uncommon; transient and comparable between the two types of toxin. A clinical note at the end of this review comments on fine clinical points. Administration of BoNTs into salivary glands is currently the most effective way of treating sialorrhea.
Keywords: botulinum neurotoxins; botox; drooling; pytialis; double-blind; therapy; topical agents; oral agents
PDF Full-text Download PDF Full-Text [774 KB, Updated Version, uploaded 23 May 2013 07:54 CEST]
The original version is still available [787 KB, uploaded 21 May 2013 12:11 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Lakraj, A.A.; Moghimi, N.; Jabbari, B. Sialorrhea: Anatomy, Pathophysiology and Treatment with Emphasis on the Role of Botulinum Toxins. Toxins 2013, 5, 1010-1031.

AMA Style

Lakraj AA, Moghimi N, Jabbari B. Sialorrhea: Anatomy, Pathophysiology and Treatment with Emphasis on the Role of Botulinum Toxins. Toxins. 2013; 5(5):1010-1031.

Chicago/Turabian Style

Lakraj, Amanda A.; Moghimi, Narges; Jabbari, Bahman. 2013. "Sialorrhea: Anatomy, Pathophysiology and Treatment with Emphasis on the Role of Botulinum Toxins." Toxins 5, no. 5: 1010-1031.

Toxins EISSN 2072-6651 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert